Arkolith/Insider Trading/AMPE/Form 4

Buchi J Kevin

DirectorAmpio Pharmaceuticals, Inc. (AMPE) · full profile →Form 4 · filed May 16, 2023
Net Buying
Open-Market Buys
$17K
Open-Market Sells
$0
Net Open-Market Flow
$17K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 15, 2023Buy(P)44K$0.25$11K67K
May 12, 2023Buy(P)23K$0.24$6K23K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001615594-23-000032) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML